Results 121 to 130 of about 2,524 (195)

Maternal RSV Vaccination and Complementary Infant-Protection Strategies in Singapore: A Modified Nominal Group Technique Consensus Study. [PDF]

Pathogens
Chong CY, Goh A, Kale AS, Kang JHL, Lee BW, Mathur M, Tagore S.   +6 more
europepmc   +1 more source

Nirsevimab for respiratory syncytial virus prevention: A comprehensive product review. [PDF]

Hum Vaccin Immunother
Razzini JL, Martinon-Torres F.
europepmc   +1 more source

Reply to Hodges et al. Comment on "Kura et al. Cost-Effectiveness Analysis of Clesrovimab for Respiratory Syncytial Virus in Infants in the United States. <i>Vaccines</i> 2026, <i>14</i>, 411". [PDF]

Vaccines (Basel)
Kura K, Lang JC, Wang D, Choi Y, Goveia MG, Sinha A, Chen YH, Elbasha EH.   +7 more
europepmc   +1 more source

Maternal Vaccination vs Nirsevimab Use and Respiratory Syncytial Virus Infection Among Full-Term Infants.

JAMA Netw Open
Jacobson KB, Watson AJ, Liao LD, Stephens SC, Merchant M, Zerbo O, Klein NP.   +6 more
europepmc   +1 more source

Nirsevimab rollout in the Gulf Cooperation Council, scoping review protocol

Protocol for a PRISMA-ScR scoping review of nirsevimab implementation across the six Gulf Cooperation Council countries during the 2024 to 2025 and 2025 to 2026 RSV seasons, with cost-effectiveness modeling for Kuwait, Qatar, Bahrain, and Oman ...
Rabia Shah
core  

Detection of a Nirsevimab-Resistant RSV-B Variant (F:K68Q) in an Adult with Severe Infection. [PDF]

Infect Dis Ther
de Prost N, Le Goff M, Cappy P, Bay P, N'debi M, Soulier A, Pawlotsky JM, Rodriguez C, Fourati S.   +8 more
europepmc   +1 more source

Beyond Efficacy: Policy, Delivery, and Equity Determinants of Long-Acting Monoclonal Antibody Uptake for Infant RSV Prevention-A WAidid Consensus Document. [PDF]

Vaccines (Basel)
Esposito S, Abu-Raya B, Eley B, Halasa N, Martinon-Torres F, Mejias A, Spoulou V, Tenenbaum T, Torres JP, Osterhaus A, Ramilo O, Principi N.   +11 more
europepmc   +1 more source

Association between nirsevimab coverage and pediatric emergency department visits for bronchiolitis in 12 European countries: An interrupted time-series analysis. [PDF]

PLoS Med
Lenglart L, Titomanlio L, Alberti I, Almeida L, Aupiais C, Akyüz Özkan E, Barrett M, Basmaci R, Birbilen A, Borensztajn D, Schönenberger CB, Bressan S, Buonsenso D, Campos T, Castanhinha S, Chiaretti A, Claret G, De Zan F, Durnin S, Fodor L, Gomez B, Greber-Platzer S, Guedj R, Huege A, Leonard F, Maconochie IK, Marlow R, Milani G, Molina Gutierrez MA, Musolino AM, Oostenbrink R, Pucuka Z, Rivière S, Roland D, Rinder MR, Supino MC, Teksam O, Trenchs V, Valtuille Z, Vanda B, Vrijlandt S, Ouldali N, Nijman RG, EPISODES Study Group.   +43 more
europepmc   +1 more source

Real-World Effectiveness of Nirsevimab Against RSV-LRTI and Bronchiolitis Hospitalization: Results from the 2024-2025 Italian Universal Immunization Campaign in Newborns. [PDF]

Viruses
Auriti C, Gizzi C, Riccò M, Bellù R, Giuffrè M, Fabiano A, Cacace C, Cavicchioli P, Cuttano A, Valerio SD, Germini C, Napolitano M, Paviotti G, Peila C, Perrone S, Pesce S, Scarpelli G, Scutti G, Spanedda G, Staffler A, Agosti M, On Behalf Of The Italian Working Group On Rsv Prophylaxis Of Italian Society Of Neonatology.   +21 more
europepmc   +1 more source

Viral replacement or proportional change? Respiratory surveillance as RSV prevention expands in Latin America. [PDF]

Lancet Reg Health Am
Avila-Aguero ML, Falleiros-Arlant LH, Brea J, Saez-Llorens X, Gentile A.   +4 more
europepmc   +1 more source